Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of lecithin and health products, applied in the field of lecithin health products, can solve problems such as not suitable for long-term use, low conversion rate of lecithin, hemolysis, etc., and achieve the goal of alleviating Alzheimer's disease, cerebrovascular sclerosis, and repairing neural structures Effect
Inactive Publication Date: 2017-01-04
何灌生
View PDF8 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0008] However, in the prior art, soybean lecithin has a certain amount of blood-soluble lecithin, so it should not be taken for a long time, otherwise it will cause hemolysis, which is unfavorable to the human body; meanwhile, in the prior art, the conversion rate of lecithin is very low and cannot Achieve the purpose of treating diseases, or have no effect on diseases such as mental illness and Alzheimer's disease
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0020] A lecithin health product, which is mainly composed of lecithin and fatty acid mixture, the lecithin is egg lecithin, and the fatty acid is composed of palmitic acid, palmitoleic acid, oleic acid, linoleic acid, myristic acid, linolenic acid and Composition of docosahexaenoic acid, the weight content of egg lecithin, palmitic acid, palmitic monoenoic acid, oleic acid, linoleic acid, myristic acid, linolenic acid, docosahexaenoic acid in the main body The percentages are 8.14%, 20%, 2.5%, 40%, 19%, 0.1%, 1.3% and 0.03%; the main body in the lecithin health care products accounts for 97%, and the remaining 3% is golden sea buckthorn seeds Oil.
[0021] After all the components are dissolved, continue to stir to mix the components evenly, making it a viscous slurry; heat the mixture to 60°C, and keep it at a vacuum of -0.06--0.85MPa for 30min; The mixture is poured into a mold, which is made of stainless steel and has a round hole with a diameter of 3mm and a depth of 1.5...
Embodiment 21
[0080] A lecithin health product, different from Example 1, the egg lecithin, palmitic acid, palmitenoic acid, oleic acid, linoleic acid, myristic acid, linolenic acid docosahexa The percentages by weight of alkenoic acid are 9.7%, 20.7%, 3.2%, 42.9%, 20.1%, 0.3%, 1.5% and 0.05%, respectively.
Embodiment 211
[0082] A lecithin health product, different from Example 1, the egg lecithin, palmitic acid, palmitenoic acid, oleic acid, linoleic acid, myristic acid, linolenic acid docosahexa The percentages by weight of alkenoic acid are 8.7%, 20.7%, 3.2%, 42.9%, 20.1%, 0.3%, 1.5% and 0.05%, respectively.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a lecithin health product. The lecithin health product uses a mixture of lecithin and aliphatic acid as a main body; the aliphatic acid comprises palmitic acid, palmitoleic acid, oleic acid and linoleic acid; the lecithin is egg lecithin; and the weight percentages of egg lecithin, palmitic acid, palmitoleic acid, oleic acid and linoleic acid in the main body are 8 to 12%, 20 to 21%, 2.5 to 3.5%, 40 to 44% and 19 to 21.5%, respectively. The lecithin health product employs non-hemolytic lecithin, can be taken for a long time, has no toxicity and can treat a variety of heart diseases, hypertension, diabetes type II accompanied by hyperlipidemia, hepatitis B and angina pectoris; and the lecithin health product can also repair a nervous structure, treat or alleviate senile dementia, lower cholesterol, mitigate cerebral angiosclerosis and improve microcirculation.
Description
technical field [0001] The invention belongs to the technical field of health products, in particular, the invention relates to a lecithin health product. Background technique [0002] The lipids that make up cell membranes are mainly phospholipids. Among the phospholipids, lecithin accounts for the majority. Therefore, phospholipids are an important component of biological membranes. In addition to the dry weight percentage (%) of water in the human body, lecithin accounts for 43% in red blood cells, 79% in nerve sheath (myelin sheath), 49% in retina, and 49% in mitochondrial membranes in liver cells. Phospholipids account for 24%, while liver cell mitochondrial outer membrane, its lecithin accounts for 48%. It can be seen that lecithin is an indispensable part of human cells. [0003] Lecithin is needed for human nutrition. It can regulate the lipids in human serum. It can also protect the heart, nourish the brain, improve intelligence, promote the formation of cell me...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more